Glenmark Pharmaceuticals Limited is a global pharmaceutical company. The Company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW). It has approximately seven molecules, over two NCEs and approximately five NBEs in various stages of pre-clinical and clinical development. It is focused on developing and marketing branded and generic formulations.
SHORT TERM PERSPECTIVE
|Company||Glenmark Pharma Ltd.|
|Stop Loss (SL)||Rs.395|
|Time Horizon||2-4 Weeks|
Intermediate and short term trend is up in this stock. After a sharp up move, the stock has had a moil correction and started its upwards journey once again. The stock is continuously making a higher top and higher bottom formation on the daily chart which is bullish in nature. The stock has taken the gap support and during the correction phase we saw volumes shrink. The up move has resumed with increase in volume and positive diversion from oscillator indicate that stock can move higher from current levels so one can accumulate the stock at CMP With a stop loss of Rs. 395 on closing basis and for the target Price of Rs 475-490. Time frame should be 2-4 weeks.
DISCLOSURE IN PURSUANCE OF SECTION 19 OF SEBI (RA) REGULATION 2014
Elite Wealth Advisors Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Advisors Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as read more
For Daily Share Market Updates, Daily debt market review, Market Research Analysis reports, Weekly Techno-Funda Report, Fundamental Analysis Report, Monthly Recommended stock Picks, Equity Trading Tips, Upcoming IPO/NFO/Bonds/Ncd’s updates & other related information Subscribe our research plan